Hana Biosciences, Inc. - Earning & Dividend Analysis Snapshot

This detailed Report provides an Earnings and Dividends history for Hana Biosciences, Inc.. Tabular results include up to a ten-year history of "as reported" Earnings per Share and Dividends per Share plus a calculation of the amount of earnings paid out over the year in dividends (i.e. Payout Ratio). Earnings and Dividends are presented on both a Quarterly and Annual basis. An annual Percent Change factor is calculated for both Earnings and Dividends.

Hana Biosciences, Inc.. The Group's principle activity is to acquire, develop and commercialize of innovative biopharmaceutical products to advance cancer care. It has four product candidates in various stages of development: Marqibo being developed for the treatment of adult acute lymphoblastic leukemia (ALL) and metastatic uveal melanoma. Menadione, a novel supportive care product candidate being developed for the prevention and/or treatment of the skin toxicities associated with the use of epidermal growth factor receptor inhibitors (EGFRI), a type of anti-cancer agent used in the treatment of certain cancers. Brakiva developed for the treatment of solid tumors including small cell lung cancer and ovarian cancer. Alocrest developed for the treatment of solid tumors such as non-small-cell lung cancer (NSCLC).

Not the Report you are looking for? Click here for more browsing options.

view sample Single Report

view sample All Basic Reports

Layout and Content of a Typical Report